Fig. 2. The workflow of the Rare Diseases Models and Mechanisms network. As a MO-based research network established initially in Canada, the Rare Diseases Models and Mechanisms (RDMM) network is structured in a committee basis. A project in the RDMM network is initiated with a submission of a “Connection Application” from clinicians who identify patients with rare genetic diseases. Once reviewed by the Clinical Advisory Committee, the approved applications are forwarded to the Scientific Advisory Committee for their search of matching MO scientists enrolled in the RDMM Registry. The MO scientists recruited by the Scientific Advisory Committee are then requested to submit a “Model Organism Proposal Application” to the committee. Following an approval of this proposal, MO scientists receive a catalyst fund to initiate an immediate collaborative research with clinicians who submitted the “Connection Application”.
© Exp Neurobiol
